Skip to main content
OpenTrials
Completed

NCT Number: NCT06097130

Batch Fermentation and Microbiome Analysis

The correlation between diet and microbiota as well as the effect of microbiota on human health is well established. Studies have shown that people following specific diets have different microbiome profile compared to those following traditional or ordinary diets. In order to screen several food ingredients for their effects on human microbiota composition and metabolic activities, in vitro studies are proposed. Nutrients are added in-vitro in fecal sample, eliminating the need for participants to consume any nutritional product. The batch fermentation in vitro system simulates human colonic microbiota from fecal samples, enabling the complex mixture of microorganisms. This system could serve as a simple model to simulate the diversity as well as the metabolism of human colonic microbiota. We will evaluate the effect on nutrient/s on the age specific microbiome via an in vitro fermentation approach for the 0 to 60 year-old period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

0 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Nestle Clinical Innovation Lab

Lausanne, Canton of Vaud, 1000, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy participant aged from 0 to 60 (based on medical history, physical examination and review of childhood growth chart)
  • Written informed consent has been obtained from the parent(s)/legally acceptable representative (LAR) of toddlers and teenagers
  • Written informed consent has been obtained for participants aged from 14 years old and above
  • Child's parent(s)/legal representative or participant is willing and able to fulfill the requirements of the study protocol.
  • Ability to collect their or their infant/child's fecal sample.

Exclusion criteria

  • The parent(s)/legally acceptable representative (LAR) is not able to provide evidence of parental authority or legal representation.
  • Participant following a particular regimen of any type such as vegan, vegetarian, ketogenic, paleo diet,
  • Chronic or recurrent diarrhea with spontaneous bowel movements more often than 2 times daily,
  • Antibacterial/antifungal therapy during the 3 months prior to study enrolment,
  • Medications or supplements that are known to alter gut function or microbiota (i.e. acid antisecretory drugs, pre-/probiotics supplements, laxatives) during the 4 weeks prior to study enrolment,
  • Prior gastrointestinal surgery (apart from appendectomy, cholecystectomy or herniotomy),
  • Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer,
  • Artificially sweetened beverage intake higher than 1000 ml/ per day,
  • Current or history of gastrointestinal diseases like (Celiac Disease, Crohn's Disease, Ulcerative colitis, Irritable Bowel Syndrome, infantile colic, recurrent abdominal pain, functional constipation, ulcers, infections (based on anamnesis),
  • Participants participating in another interventional study,
  • Participants/parents having a hierarchical or family link with the research team members.

Treatment and study plan

Primary outcomes

  1. Change in microbiota composition

    Time frame: Through study completion, an average of 1 year

    Measured by 16s rRNA sequencing or next Generation Sequencing (NGS) or by qPCR

Secondary outcomes

  1. Change in Short Chain Fatty Acids (SCFA)

    Time frame: Through study completion, an average of 1 year

    Measured using Gas Chromatography (GC)

  2. Change in metabolic profile

    Time frame: Through study completion, an average of 1 year

    Measured using Gas Chromatography (GC) or Gas chromatography-mass spectrometry (GC-MS)

  3. Protein expression of epithelial cells

    Time frame: Through study completion, an average of 1 year

    Measured by western blot

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Registry information

Official study title

Evaluation of the Effect of Different Nutrients on the Gut Microbiota Composition and Metabolic Activity by Using in Vitro Batch Fermentation and Cellular Models

Important dates

Study start
2020
Primary completion
2020
Study completion
2025
First posted
Oct 24, 2023
Registry last updated
Dec 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.